Author Affiliations: Divisions of General Internal Medicine (Dr Matlock) and Cardiology (Dr Allen), Department of Medicine, University of Colorado School of Medicine, Aurora; and Colorado Cardiovascular Outcomes Research Consortium, Denver (Drs Matlock and Allen).
In a medical culture where death is too often viewed as failure, clinicians and patients struggle to have high-quality discussions about deactivating an implantable cardioverter-defibrillator (ICD). The implications of this inaction are not trivial. In approximately half of hospices over the course of a year, patients dying of incurable disease will be shocked by their ICDs.1 Multiple societies have made recent calls for increased communication around ICD deactivation.2,3 However, exactly what form those conversations should take has yet to be determined.
Matlock DD, Allen LA. Defibrillators, Deactivation, Decisions, and Dying : Comment on “Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators”. JAMA Intern Med. 2013;173(5):379–380. doi:10.1001/jamainternmed.2013.2130
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: